Bullish Options Positioning in Hain Celestial (HAIN) with Shares Down 17% Today Following Q2 Earnings Miss -Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
Go back to Bullish Options Positioning in Hain Celestial (HAIN) with Shares Down 17% Today Following Q2 Earnings Miss -Susquehanna
February 7, 2019 11:07 AM EST
Increasing unusual call option volume: EXP HAIN MGNX QNST LIVN SOXS IRBT CMG MHK HBI GRUB SONO MTCH
...
More
February 7, 2019 9:27 AM EST
Today's Pre-Open Movers
Solid Biosciences (Nasdaq: SLDB) 72.8% LOWER; announced today preliminary findings from IGNITE DMD, the Companys Phase I/II dose-ascending clinical trial evaluating the safety and efficacy of SGT-001 microdystrophin gene transfer for the treatment of Duchenne muscular dystrophy (DMD). Initial three-month biopsy data showed low levels of microdystrophin protein expression. The Company is currently engaging with the appropriate parties to dose escalate as planned and as soon as possible.
OraSure Technologies (NASDAQ: OSUR) 18% LOWER;... More
February 7, 2019 7:44 AM EST
Hain Celestial (NASDAQ: HAIN) to Resume Trading at 8 am ET
...
More
February 7, 2019 7:32 AM EST
Hain Celestial (NASDAQ: HAIN) reported Q2 EPS of $0.14, $0.12 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $584.2 million versus the consensus estimate of $613.15 million.
GUIDANCE:
Hain Celestial sees FY2019 EPS of $0.60-$0.70, versus the consensus of... More
February 7, 2019 7:25 AM EST
Hain Celestial (NASDAQ: HAIN) Halted, News Pending
...
More
